Antimicrobial Treatment of Multiple Sclerosis

Infection 2007.35.5 pp 383 - 385

Stratton CW The Vanderbilt University Medical Centre, Nashville, TN, USA
Wheldon DB The Department of Medical Microbiology, Bedford Hospital, Bedford, UK

A letter which details a strategy for the treatment of chronic infections in which Chlamydia (Chlamydophila) pneumoniae is implicated. (A response to an article which found that monotherapy with roxithromycin did not ameliorate Multiple Sclerosis.)

The full text of the letter is available through this link:

Return to Multiple Sclerosis index page here.

Uploaded 25th December 2011
Revised 6th February 2012